Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.14 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |